Cheminformatic Tools and Databases for Pharmacology

session 51830 - Total of 1 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
LANREOTIDE

LANREOTIDE


ATC H01CB03

HORMONES
SOMATOSTATIN ANALOG
LONG-TERM TREATMENT OF ACROMEGALIC PATIENTS
INHIBITOR OF VARIOUS ENDOCRINE, NEUROENDOCRINE, EXOCRINE AND PARACRINE FUNCTIONS
REDUCTION OF GH AND/OR IGF-1 LEVELS

SUBCUTANEOUS

Cmax 5.7 NANOMOLAR

Tmax 9.5 HOUR

F 78.4 PERCENT (120 MILLIGRAM)

VD 13 LITER (65 KILOGRAM)

PPB 81 PERCENT

Cl 23.7 LITER / HOUR

HT 636 HOUR

SOMATOSTATIN RECEPTORS (SSTR) 2 AND 5
REDUCED BINDING AFFINITY FOR HUMAN SSTR1, 3, AND 4

SOMATOSTATIN RECEPTOR 2 AGONIST CHEMBL1804 SOMATOSTATIN RECEPTOR 2 P30874 SOMATOSTATIN RECEPTOR TYPE 2 HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 PEPTIDE SHORT PEPTIDE SOMATOSTATIN RECEPTORANSM (in French)

Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |